RAC1 and pancreatic neoplasm: Treatment with 10 μM AR-A014418 reduced the levels of p-FAKY397 and p-FAKY861 (Fig. 6D), suggesting a pivotal role for the GSK3β/FAK/Rac1 pathway in promoting pancreatic cancer cell invasion.